# RNN 2nd Gen Model Humana Inc. Hospital & medical service plans

Stock predictor AI models:
Subscribe >> Deal exit on
Nov. 24, 2020
Deal entry on
Nov. 24, 2020
4.68%Expected margin
66.67% successful of 54 deals
$ 409.29 Last close price
at 23-nov-2020

HUM

Model's trade recommendations 7.26% Return for period

-24.84% Annual return

$39.61B Market Cap

β 0.95  

HUM

Model (following trade recommendations)

HUM

Underlying stock

S&P 500

Index
Return for period 7.26%
-5.29%
1.78%
52wk return -40.12%
18.70%
16.82%
52wk Range
214.43—452.01
2000.54—2399.63
Sortino ratio -0.73
Sharpe ratio -0.71
Norm. RMSE 6.67%
Downside risk 30.91%
Volatility 0.00%
  • 2.00 (0.70%) Div (Yield)
  • STRONG BUY Analysts consensus recommendation

Humana Inc. is committed to helping their millions of medical and specialty members achieve their best health. Their successful history in care delivery and health plan administration is helping them create a new kind of integrated care with the power to improve health and well-being and lower costs. Their efforts are leading to a better quality of life for people with Medicare, families, individuals, military service personnel, and communities at large.

Industry sector: Medical

Sector classification: Hospital & medical service plans

Deep Learning based analysis and prediction model for Humana Inc. (HUM) stock is a 2nd Generation Non-linear Autoregressive (NAR) model based on the LSTM/GRU Recurrent Neural Network architecture.

Model is in the production pipeline since Sept. 30, 2015.

Market data for HUM model training are being downloaded from the Quandl premium datasets on a daily basis.
Risks related to the novel coronavirus disease 2019 (COVID-19) caused by the virus named “SARS-CoV-2” are accounted for in this model in the form of the historical data coincided with outbreaks and other global events in the past used to train ML prediction model for HUM.

Model is being retrained on a regular basis.

Float 137M
P/E 23.39
Shares Outstanding 138M
% Held by Insiders 0.60%
% Held by Institutions 96.61%
EPS (last reported FY) $11.71
EPS (last reported Q) $3.36
EPS, estimated (last reported Q) $3.21
Total revenues $54 B
Net income $2 B